DOCCHECK AG (AJ91.DE) Stock Fundamental Analysis
Europe - FRA:AJ91 - DE000A1A6WE6 - Common Stock
12.4 EUR
0 (0%)
We assign a fundamental rating of 6 out of 10 to AJ91. AJ91 was compared to 10 industry peers in the Health Care Technology industry. AJ91 has an excellent financial health rating, but there are some minor concerns on its profitability. AJ91 is not valued too expensively and it also shows a decent growth rate. AJ91 also has an excellent dividend rating. These ratings could make AJ91 a good candidate for dividend investing.
1. Profitability
1.1 Basic Checks
In the past year AJ91 was profitable.
In the past year AJ91 had a positive cash flow from operations.
AJ91 had positive earnings in each of the past 5 years.
AJ91 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
AJ91's Return On Assets of 9.09% is fine compared to the rest of the industry. AJ91 outperforms 80.00% of its industry peers.
AJ91 has a better Return On Equity (13.18%) than 70.00% of its industry peers.
AJ91 has a Return On Invested Capital (8.86%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for AJ91 is in line with the industry average of 9.03%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.09% | ||
| ROE | 13.18% | ||
| ROIC | 8.86% |
ROA(3y)7.87%
ROA(5y)12.82%
ROE(3y)11.84%
ROE(5y)19.17%
ROIC(3y)9.31%
ROIC(5y)15.17%
1.3 Margins
AJ91 has a Profit Margin of 9.82%. This is comparable to the rest of the industry: AJ91 outperforms 60.00% of its industry peers.
AJ91's Profit Margin has been stable in the last couple of years.
With a decent Operating Margin value of 12.33%, AJ91 is doing good in the industry, outperforming 70.00% of the companies in the same industry.
AJ91's Operating Margin has declined in the last couple of years.
AJ91's Gross Margin of 79.18% is in line compared to the rest of the industry. AJ91 outperforms 60.00% of its industry peers.
AJ91's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.33% | ||
| PM (TTM) | 9.82% | ||
| GM | 79.18% |
OM growth 3Y-13.6%
OM growth 5Y-2.73%
PM growth 3Y-9.54%
PM growth 5Y0.26%
GM growth 3Y11.03%
GM growth 5Y-0.26%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AJ91 is creating some value.
Compared to 1 year ago, AJ91 has about the same amount of shares outstanding.
AJ91 has more shares outstanding than it did 5 years ago.
AJ91 has a better debt/assets ratio than last year.
2.2 Solvency
AJ91 has an Altman-Z score of 4.40. This indicates that AJ91 is financially healthy and has little risk of bankruptcy at the moment.
AJ91 has a better Altman-Z score (4.40) than 80.00% of its industry peers.
AJ91 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.4 |
ROIC/WACC1.27
WACC6.99%
2.3 Liquidity
A Current Ratio of 2.74 indicates that AJ91 has no problem at all paying its short term obligations.
AJ91 has a Current ratio of 2.74. This is amongst the best in the industry. AJ91 outperforms 90.00% of its industry peers.
AJ91 has a Quick Ratio of 2.50. This indicates that AJ91 is financially healthy and has no problem in meeting its short term obligations.
AJ91's Quick ratio of 2.50 is amongst the best of the industry. AJ91 outperforms 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.74 | ||
| Quick Ratio | 2.5 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 133.18% over the past year.
The Earnings Per Share has been growing by 10.57% on average over the past years. This is quite good.
AJ91 shows a small growth in Revenue. In the last year, the Revenue has grown by 0.69%.
Measured over the past years, AJ91 shows a quite strong growth in Revenue. The Revenue has been growing by 10.68% on average per year.
EPS 1Y (TTM)133.18%
EPS 3Y-22.65%
EPS 5Y10.57%
EPS Q2Q%501.79%
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-14.46%
Revenue growth 5Y10.68%
Sales Q2Q%7.91%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 11.92, the valuation of AJ91 can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of AJ91 indicates a rather cheap valuation: AJ91 is cheaper than 90.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of AJ91 to the average of the S&P500 Index (26.11), we can say AJ91 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.92 | ||
| Fwd PE | N/A |
4.2 Price Multiples
AJ91's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AJ91 is cheaper than 90.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AJ91 is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.66 | ||
| EV/EBITDA | 3.94 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)1.13
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
AJ91 has a Yearly Dividend Yield of 6.05%, which is a nice return.
Compared to an average industry Dividend Yield of 3.43, AJ91 pays a better dividend. On top of this AJ91 pays more dividend than 100.00% of the companies listed in the same industry.
AJ91's Dividend Yield is rather good when compared to the S&P500 average which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.05% |
5.2 History
The dividend of AJ91 has a limited annual growth rate of 4.52%.
Dividend Growth(5Y)4.52%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
48.02% of the earnings are spent on dividend by AJ91. This is a bit on the high side, but may be sustainable.
AJ91's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP48.02%
EPS Next 2YN/A
EPS Next 3YN/A
FRA:AJ91 (10/31/2025, 7:00:00 PM)
12.4
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners8.86%
Inst Owner ChangeN/A
Ins Owners71.92%
Ins Owner ChangeN/A
Market Cap62.87M
Revenue(TTM)53.79M
Net Income(TTM)5.28M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.05% |
Yearly Dividend0.5
Dividend Growth(5Y)4.52%
DP48.02%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.92 | ||
| Fwd PE | N/A | ||
| P/S | 1.17 | ||
| P/FCF | 9.66 | ||
| P/OCF | 8.23 | ||
| P/B | 1.57 | ||
| P/tB | 1.58 | ||
| EV/EBITDA | 3.94 |
EPS(TTM)1.04
EY8.39%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.28
FCFY10.35%
OCF(TTM)1.51
OCFY12.15%
SpS10.61
BVpS7.91
TBVpS7.87
PEG (NY)N/A
PEG (5Y)1.13
Graham Number13.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.09% | ||
| ROE | 13.18% | ||
| ROCE | 14.96% | ||
| ROIC | 8.86% | ||
| ROICexc | 17.58% | ||
| ROICexgc | 17.72% | ||
| OM | 12.33% | ||
| PM (TTM) | 9.82% | ||
| GM | 79.18% | ||
| FCFM | 12.1% |
ROA(3y)7.87%
ROA(5y)12.82%
ROE(3y)11.84%
ROE(5y)19.17%
ROIC(3y)9.31%
ROIC(5y)15.17%
ROICexc(3y)16.17%
ROICexc(5y)32.75%
ROICexgc(3y)16.36%
ROICexgc(5y)34.31%
ROCE(3y)15.72%
ROCE(5y)25.61%
ROICexgc growth 3Y-26.82%
ROICexgc growth 5Y-2.82%
ROICexc growth 3Y-26.26%
ROICexc growth 5Y-1.57%
OM growth 3Y-13.6%
OM growth 5Y-2.73%
PM growth 3Y-9.54%
PM growth 5Y0.26%
GM growth 3Y11.03%
GM growth 5Y-0.26%
F-Score6
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 45.88% | ||
| Cap/Sales | 2.11% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.94% | ||
| Profit Quality | 123.15% | ||
| Current Ratio | 2.74 | ||
| Quick Ratio | 2.5 | ||
| Altman-Z | 4.4 |
F-Score6
WACC6.99%
ROIC/WACC1.27
Cap/Depr(3y)102.11%
Cap/Depr(5y)131.26%
Cap/Sales(3y)5.41%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)133.18%
EPS 3Y-22.65%
EPS 5Y10.57%
EPS Q2Q%501.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-14.46%
Revenue growth 5Y10.68%
Sales Q2Q%7.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y86.96%
EBIT growth 3Y-26.09%
EBIT growth 5Y7.66%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.74%
FCF growth 3Y-1.99%
FCF growth 5Y54.46%
OCF growth 1Y1.69%
OCF growth 3Y-11.25%
OCF growth 5Y33.53%
DOCCHECK AG / AJ91.DE FAQ
Can you provide the ChartMill fundamental rating for DOCCHECK AG?
ChartMill assigns a fundamental rating of 6 / 10 to AJ91.DE.
Can you provide the valuation status for DOCCHECK AG?
ChartMill assigns a valuation rating of 5 / 10 to DOCCHECK AG (AJ91.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for DOCCHECK AG?
DOCCHECK AG (AJ91.DE) has a profitability rating of 5 / 10.
What is the valuation of DOCCHECK AG based on its PE and PB ratios?
The Price/Earnings (PE) ratio for DOCCHECK AG (AJ91.DE) is 11.92 and the Price/Book (PB) ratio is 1.57.
Can you provide the dividend sustainability for AJ91 stock?
The dividend rating of DOCCHECK AG (AJ91.DE) is 8 / 10 and the dividend payout ratio is 48.02%.